Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2025 · first_quarter · 1T
PBM Price Reforms,
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2024 · fourth_quarter · Q4
Source: Senate LDA
| COMMUNICATIONS WORKERS OF AMERICA |
| 4 |
| 1999–2000 |
| SHUTTLE AMERICA | 4 | 1999 |
| UNITED PARCEL SERVICE | 4 | 2000–2002 |
| AMERICAN PETROLEUM INST (API) | 2 | 1999 |
| REPUBLIC HOLDINGS CORPORATION | 2 | 2008 |
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
DRUG Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
H.R. 3 - Price controls for prescription drugs.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
H.R. 3 - Price controls for prescription drugs. Importation of drugs from other countries.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
H.R. 3 - Price controls for prescription drugs. Importation of drugs from other countries.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
H.R. 3 Lower Drug Prices- Cummings Act Drug importation from Canada
Competitive DRUGS Act of 2019
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
HR. 1344 Competitive DRUGS Act of 2019
Competitive DRUGS Act of 2019
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
HR. 1344 Competitive DRUGS Act of 2019 Drug importation from Canada
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation from Canada HR 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Drug importation from Canada HR 3 Lower Drug Costs Now Act of 2019
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697 Employment issues in chemical legislation.
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697
Innovation Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Medicare Part-D rebates Trade agreements Patent reform legislation H.R. 9
Innovation Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Medicare Part-D rebates Trade agreements Patent reform legislation H.R. 9
Innovation Act
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Medicare Part-D rebates Trade agreements Patent reform legislation H.R. 9
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697
Frank R. Lautenberg Chemical Safety for the 21st Century Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA reform. S.697
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
Chemical Safety Improvement Act S.1009
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
Toxic Substance Control Act reform S.1009
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
S.1009 Chemical Safety Act
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA Reform S.1009
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL, INC. · Firm: FLYNN & ASSOCIATES, INC.
TSCA Reform S.1009
Patent Reform Act of 2007
Client: PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION · Firm: FLYNN & ASSOCIATES, INC.
Patent Reform S.1145
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2024 · third_quarter · Q3
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2024 · second_quarter · Q2
Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2024 · first_quarter · Q1
Drug importation Price controls Pharmacy Benefit Manager issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2023 · fourth_quarter · Q4
Drug importation Price controls Pharmacy Benefit Manager issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2023 · third_quarter · Q3
Drug importation Price controls Pharmacy Benefit Manager issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2023 · second_quarter · Q2
Drug importation Price controls
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2023 · first_quarter · Q1
Drug importation Price controls
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2022 · fourth_quarter · Q4
Price controls for prescription drugs. Importation of drugs from other countries. Prescription Drug User Fee Act (reauthorization).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2022 · third_quarter · Q3
Price controls for prescription drugs. Importation of drugs from other countries. Prescription Drug User Fee Act (reauthorization).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2022 · second_quarter · Q2
Price controls for prescription drugs. Importation of drugs from other countries. Prescription Drug User Fee Act (reauthorization).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2022 · first_quarter · Q1
Price controls for prescription drugs. Importation of drugs from other countries. Prescription Drug User Fee Act (reauthorization).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2021 · fourth_quarter · Q4
Price controls for prescription drugs. Importation of drugs from other countries. Build Back Better Act (Medicare Part D negotiations).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2021 · third_quarter · Q3
H.R. 3 - Price controls for prescription drugs. Importation of drugs from other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2021 · second_quarter · Q2
H.R. 3 - Price controls for prescription drugs. Importation of drugs from other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2021 · first_quarter · Q1
H.R. 3 - Price controls for prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2020 · fourth_quarter · Q4
Drug Price controls Drug importation from Canada
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2020 · third_quarter · Q3
Drug Price controls Drug importation from Canada
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2020 · second_quarter · Q2
ACA Stabilization - Drug Pricing Drug importation from Canada
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2020 · first_quarter · Q1
H.R. 3 Lower Drug Prices- Cummings Act Drug importation from Canada
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2019 · fourth_quarter · Q4
Drug importation from Canada HR 3 Lower Drug Costs Now Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2019 · third_quarter · Q3
Drug importation from Canada HR 3 Lower Drug Costs Now Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2019 · second_quarter · Q2
HR. 1344 Competitive DRUGS Act of 2019 Drug importation from Canada
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2019 · first_quarter · Q1
HR. 1344 Competitive DRUGS Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2018 · fourth_quarter · Q4
Childrens Health Insurance Program Importation of drugs from Canada Medicare Part D - Rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2018 · third_quarter · Q3
Childrens Health Insurance Program Importation of drugs from Canada Medicare Part D - Rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2018 · second_quarter · Q2
Childrens Health Insurance Program Importation of drugs from Canada Medicare Part D - Rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2018 · first_quarter · Q1
Childrens Health Insurance Program Importation of drugs from Canada
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2017 · fourth_quarter · Q4
Childrens Health Insurance Program Importation of drugs from Canada PDUFA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2017 · third_quarter · Q3
PDUFA Reauthorization Importation of drugs from Canada
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2017 · second_quarter · Q2
PDUFA Reauthorization Importation of drugs from overseas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2017 · first_quarter · Q1
PDUFA Reauthorization Importation of drugs from overseas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2017 · first_quarter · Q1
TSCA implementation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2016 · fourth_quarter · Q4
TSCA reform. S.697 Employment issues in chemical legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2016 · fourth_quarter · Q4
Medicare Part-D rebates Trade agreements Patent reform issues Medicare Part-B Doctor reimbursement regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2016 · third_quarter · Q3
TSCA reform. S.697
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2016 · third_quarter · Q3
Medicare Part-D rebates Trade agreements Patent reform issues Medicare Part-B Doctor reimbursement regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2016 · second_quarter · Q2
TSCA reform. S.697
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2016 · second_quarter · Q2
Medicare Part-D rebates Trade agreements Patent reform issues Medicare Part-B Doctor reimbursement regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2016 · first_quarter · Q1
TSCA reform. S.697
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2016 · first_quarter · Q1
Medicare Part-D rebates Trade agreements Patent reform issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2015 · fourth_quarter · Q4
TSCA reform. S.697
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2015 · fourth_quarter · Q4
Medicare Part-D rebates Trade agreements Patent reform legislation H.R. 9
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2015 · third_quarter · Q3
TSCA reform. S.697
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2015 · third_quarter · Q3
Medicare Part-D rebates Trade agreements Patent reform legislation H.R. 9
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2015 · second_quarter · Q2
TSCA reform. S.697
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2015 · second_quarter · Q2
Medicare Part-D rebates Trade agreements Patent reform legislation H.R. 9
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2015 · first_quarter · Q1
Medicare Part-D rebates Trade agreements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2015 · first_quarter · Q1
TSCA reform. S.697
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2014 · fourth_quarter · 4A
Patent Reform Trans Pacific Partnership Agreement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2014 · fourth_quarter · Q4
S.1009 Chemical Safety Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2014 · third_quarter · Q3
Toxic Substance Control Act reform S.1009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2014 · third_quarter · Q3
Medicare Part-D Rebates Trade Agreements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2014 · second_quarter · Q2
TSCA Reform S.1009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2014 · second_quarter · Q2
Medicare Part-D Rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2014 · first_quarter · Q1
Medicare Part-D rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2014 · first_quarter · Q1
TSCA Reform S.1009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL, INC. via FLYNN & ASSOCIATES, INC.
2014 · first_quarter · RR
Chemical Safety Improvement Act S.1009
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2013 · fourth_quarter · Q4
Trans Pacific Partnership Agreement Medicare Part-D rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2013 · third_quarter · Q3
Trans Pacific Partnership Agreement Medicare Part-D rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2013 · second_quarter · Q2
Trans Pacific Partnership Agreement negotiations Medicare Part-D Rebates
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2013 · first_quarter · Q1
Trans Pacific Partnership Agreement negotiations Pharmaceutical industry employment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2012 · fourth_quarter · Q4
TPP Negotiations Medicare Part-D rebates Pharmaceutical industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2012 · third_quarter · Q3
TPP Negotiations Pharmaceutical Industry Employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2012 · second_quarter · Q2
Pharmaceutical industry employment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2012 · first_quarter · Q1
FDA Reauthorization Pharmaceutical Industry Employment Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY via FLYNN & ASSOCIATES, INC.
2011 · fourth_quarter · Q4
Renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2011 · fourth_quarter · Q4
HEALTHCARE LEGISLATION PHARMACEUTICAL INDUSTRY EMPLOYMENT ISSUES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY via FLYNN & ASSOCIATES, INC.
2011 · third_quarter · Q3
Renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2011 · third_quarter · Q3
Healthcare legislation Pharmaceutical industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2011 · second_quarter · Q2
Healthcare legislation Pharmaceutical industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY via FLYNN & ASSOCIATES, INC.
2011 · second_quarter · Q2
Renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY via FLYNN & ASSOCIATES, INC.
2011 · first_quarter · Q1
Renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2011 · first_quarter · Q1
Healthcare legislation Pharmaceutical industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY via FLYNN & ASSOCIATES, INC.
2010 · fourth_quarter · Q4
Renewable energy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2010 · fourth_quarter · Q4
Pharmaceutical industry employment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY via FLYNN & ASSOCIATES, INC.
2010 · third_quarter · Q3
Renewable energy legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY via FLYNN & ASSOCIATES, INC.
2010 · third_quarter · RA
Renewable energy tax credits
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2010 · third_quarter · Q3
Pharmaceutical Industry Employment Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2010 · second_quarter · Q2
Healthcare Reform Legislation Pharmaceuticl Industry Employment Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2010 · first_quarter · Q1
Healthcare Reform Legislation Pharmaceutical Industry Employment Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2009 · fourth_quarter · Q4
Healthcare Reform legislation. Pharmaceutical Industry employment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2009 · third_quarter · Q3
Patent Life Issues Healthcare Reform Pharmaceutical industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN ADVOCACY CENTER via FLYNN & ASSOCIATES, INC.
2009 · third_quarter · Q3
Climate and energy principles including issues of cost containment, allowance allocation, technology deployment, international competitiveness and harmonization of federal and state regulatory efforts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2009 · second_quarter · Q2
State Children's Health Insurance Program Patent Reform Legislation Pharmaceutical Industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2009 · first_quarter · Q1
State Childrens Health Insurance Program Patent Reform Legislation Pharmaceutical industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN ADVOCACY CENTER via FLYNN & ASSOCIATES, INC.
2009 · first_quarter · Q1
Climate and energy principles including issues of cost containment, allowance allocation, technology deployment, international competitiveness and harmonization of federal and state regulatory efforts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN ADVOCACY CENTER via FLYNN & ASSOCIATES, INC.
2008 · fourth_quarter · Q4
Climate and energy principles including issues of cost containment, allowance allocation, technology deployment, international competitiveness and harmonization of federal and state regulatory efforts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2008 · fourth_quarter · Q4
State Childrens Health Insurance Program Pharmaceutical Industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN ADVOCACY CENTER via FLYNN & ASSOCIATES, INC.
2008 · fourth_quarter · RR
Climate and energy principles including issues of cost containment, allowance allocation, technology deployment, international competitiveness and harmonization of federal and state regulatory efforts.
NUCLEAR ENERGY INSTITUTE via FLYNN & ASSOCIATES, INC.
2008 · third_quarter · Q3
All energy issues related to nuclear energy in the United States
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2008 · third_quarter · Q3
State Childrens Health Insurance Programs Pharmaceutical Industry employment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC HOLDINGS CORPORATION via FLYNN & ASSOCIATES, INC.
2008 · second_quarter · Q2
Seeking development rights for properties owned by the Federal Government
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2008 · second_quarter · Q2
State Children's Health Insurance Program Pharmaceutical industry employment issues Intellectual Property law reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via FLYNN & ASSOCIATES, INC.
2008 · second_quarter · Q2
All energy issues related to nuclear electrical generation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC HOLDINGS CORPORATION via FLYNN & ASSOCIATES, INC.
2008 · first_quarter · Q1
Securing development rights for client, of publicly owned properties.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via FLYNN & ASSOCIATES, INC.
2008 · first_quarter · Q1
Construction of new nuclear plants and the re-licensing of existing plants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2008 · first_quarter · Q1
Children's Health Insurance Program funding
Patent Reform S.1145
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION via FLYNN & ASSOCIATES, INC.
2007 · year_end · YY
State Childrens Health Insurance Program re-authorization. Pharmaceutical industry employment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE